Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsSecurities - TradableShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Cash & Current Investments: 2022-2024

Historic Cash & Current Investments for Praxis Precision Medicines (PRAX) over the last 3 years, with Dec 2024 value amounting to $392.6 million.

  • Praxis Precision Medicines' Cash & Current Investments fell 25.17% to $267.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year increase of 29.21%. This contributed to the annual value of $392.6 million for FY2024, which is 382.86% up from last year.
  • Latest data reveals that Praxis Precision Medicines reported Cash & Current Investments of $392.6 million as of FY2024, which was up 382.86% from $81.3 million recorded in FY2023.
  • Praxis Precision Medicines' Cash & Current Investments' 5-year high stood at $392.6 million during FY2024, with a 5-year trough of $61.6 million in FY2022.
  • For the 3-year period, Praxis Precision Medicines' Cash & Current Investments averaged around $178.5 million, with its median value being $81.3 million (2023).
  • Data for Praxis Precision Medicines' Cash & Current Investments shows a peak YoY surged of 382.86% (in 2024) over the last 5 years.
  • Over the past 3 years, Praxis Precision Medicines' Cash & Current Investments (Yearly) stood at $61.6 million in 2022, then spiked by 31.95% to $81.3 million in 2023, then surged by 382.86% to $392.6 million in 2024.